Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation
A Russian prospective observational study on invasive fungal infections in patients with acute leukemia undergoing hematopoietic stem cell t…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant [NA]
This clinical trial update reports the completion and results posting of a study evaluating pre-transplant treatment with 5-azacitidine in p…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin [Phase 1, Phase 2]
Phase 1/2 trial evaluating plerixafor with G-CSF plus busulfan, fludarabine, and thymoglobulin for stem cell transplantation in leukemia pat…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors [Phase 1]
A Phase 1 study evaluating intravenous Eritoran (E5564) administered around bone marrow engraftment in leukemia patients undergoing matched …
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze [Phase 1]
Open-label pharmacokinetic study of leucovorin in patients receiving high-dose methotrexate, with or without Voraxaze, completed Phase 1.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases [NA]
Clinical trial update on donor stem cell transplantation for hematologic cancers and related diseases completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes [Phase 2]
A completed Phase 2 clinical trial evaluating vatalanib for patients with primary or secondary myelodysplastic syndromes, with results poste…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating 4'-Thio-araC (thiarabine) in advanced hematologic malignancies, including leukemia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Outpatient Neutropenic Diet Study [Phase 2]
Phase 2 outpatient neutropenic diet trial sponsored by MD Anderson Cancer Center for leukemia with neutropenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
The clinical trial evaluating blood stem cell transplants in adults and children with various hematologic cancers, sponsored by Columbia Uni…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 update on non-myeloablative allogeneic stem cell transplantation using mis-matched family donor cells purged with Campath (alemtuzum…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 study of an allogeneic non-myeloablative stem cell transplant using matched family member donor cells purged with Campath (alemtuzum…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants [Phase 1]
Phase 1 trial evaluating total body irradiation with fludarabine followed by combined umbilical cord blood transplants has completed. The tr…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [Phase 2]
A Phase 2 trial evaluating a conditioning regimen of total-body irradiation with tacrolimus and mycophenolate mofetil followed by bone marro…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating donor bone marrow transplantation for hematologic cancers has completed; the study enrolled patients with leukemia,…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating Interleukin-2 after bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R) [Phase 2]
Phase 2 trial of Proteinase 3 PR1 peptide with Montanide adjuvant, GM-CSF, and PEG-Intron in leukemia was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase 2 trial of azacitidine followed by GM-CSF in patients with myelodysplastic syndromes and leukemia was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial evaluated the use of sargramostim after bone marrow transplantation in patients with myelodysplastic syndromes; the…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors [Phase 2]
Phase 2 trial results evaluate a bortezomib-based graft-versus-host disease prophylaxis strategy after allogeneic transplantation in patient…
-
CLINICAL_TRIALS withdrawal · 2014-03-26Clinical Trial Update: Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures. [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating lipid-emulsion or nanoemulsion propofol in children undergoing ambulatory invasive procedures was with…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Clofarabine Bone Marrow Cytoreduction [Phase 2]
Phase 2 clinical trial assessing Clofarabine for bone marrow cytoreduction in leukemia; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer [Phase 3]
Phase 3 trial evaluating glutamic acid to reduce vincristine-induced nerve damage in young cancer patients; results posted after completion.